MedTrace Logo

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

NCT01961102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2016-08-09

No results posted yet for this study

Summary

It is to be achieved that in postmenopausal women through the combination of Hysteroscopy and intraoperative rapid section a positive predictive value (PPV) regarding the objective illness like endometrial cancer or adenomatous hyperplasia of 100% so as a negative predictive value (NPV) of 99%.

Conditions

Interventions

PROCEDURE

hysteroscopy/curettage in case of suspicious aspect will be done a rapid section

Sponsors & Collaborators

  • Krankenhaus Barmherzige Schwestern Linz

    lead OTHER

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2015-09-30
Completion
2016-03-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01961102 on ClinicalTrials.gov